ADUS
Addus HomeCareDDocument history
Earnings documents stored for ADUS.
Investor releaseQuarter not tagged2026-05-145 Insightful Analyst Questions From Addus HomeCare’s Q1 Earnings Call
StockStory
5 Insightful Analyst Questions From Addus HomeCare’s Q1 Earnings Call
Addus HomeCare’s first quarter results were met with a negative market reaction, largely due to revenue falling short of Wall Street’s expectations despite healthy year-on-year growth. Management cited a combination of weather-related disruption in January and flat sales volumes as factors impacting top-line performance. CEO Dirk Allison noted that while some personal care visits could not be rescheduled after severe winter storms, operational trends normalized in February and March. The company also highlighted improvements in its hospice segment and continued benefits from recent acquisitions, with rate increases in key states such as Illinois and Texas supporting margins. Is now the time to buy ADUS? Find out in our full research report (it’s free). Revenue: $363.6 million vs analyst estimates of $366.2 million (7.7% year-on-year growth, 0.7% miss) Adjusted EPS: $1.62 vs analyst estimates of $1.54 (4.9% beat) Adjusted EBITDA: $44.51 million vs analyst estimates of $44.22 million (12.2% margin, 0.7% beat) Operating Margin: 9.4%, in line with the same quarter last year Sales Volumes were flat year on year (33.8% in the same quarter last year) Market Capitalization: $1.82 billion While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention. Brian Tanquilut (Jefferies) asked about the impact and benefits of the caregiver app rollout in Texas. President and COO Heather Dixon explained that early adoption rates were encouraging and outlined plans for further deployment to boost service percentage and engagement. Raj Kumar (Stephens) inquired about rate trends in Indiana following recent acquisitions. CFO Brian Poff responded that Indiana’s rates have become more attractive, making simultaneous acquisitions particularly appealing for geographic scale. Matthew Gillmor (KeyBanc) probed sequential census trends in personal care and the effect of weather disruptions. Dixon confirmed that census improved through March, with Illinois showing particular strength, and described the dip as seasonal rather than structural. Michael Murray (RBC Capital) questioned whether SG&A leverage was due to the caregiver app or other cost initiatives. Poff...
Investor releaseQuarter not tagged2026-05-06A Look At Addus HomeCare (ADUS) Valuation After Q1 Earnings Beat And Indiana Acquisitions
Simply Wall St.
A Look At Addus HomeCare (ADUS) Valuation After Q1 Earnings Beat And Indiana Acquisitions
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Addus HomeCare (ADUS) just reported Q1 2026 results, with net income of US$25.07 million and diluted EPS of US$1.36, alongside an earnings beat and new personal care acquisitions in Indiana. See our latest analysis for Addus HomeCare. The Q1 2026 earnings beat and Indiana personal care acquisitions come after a 9.31% 1 month share price return. However, the year to date share price return of 6.06% and 1 year total shareholder return of 4.07% indicate only modest longer term progress. If this kind of healthcare story interests you, it could be worth broadening your watchlist with a few more targeted ideas using the 33 healthcare AI stocks So, with earnings surprising to the upside, acquisitions adding scale in personal care, and the stock still showing a negative 1-year total return, is there a buying opportunity here, or is the market already pricing in future growth? At a last close of $100.12 against a narrative fair value of $110.03, the current price sits below what this widely followed model implies, putting the focus squarely on its underlying assumptions. Read the complete narrative. Curious what justifies that higher fair value? The narrative leans on measured revenue growth, firmer margins, and a future earnings multiple that assumes investors stay willing to pay up. Result: Fair Value of $110.03 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, that upside story can be challenged if government healthcare budgets tighten and Medicaid reimbursement shifts, or if rising caregiver wages continue to pressure margins. Find out about the key risks to this Addus HomeCare narrative. Mixed signals on value and risk so far? Take a moment to scan the data yourself and see what stands out, then weigh those 5 key rewards If you stop with just one stock here, you could miss opportunities that fit your goals even better, so widen your search before making your next move. Spot potential value opportunities early by scanning 48 high quality undervalued stocks and seeing which stocks currently trade below their assessed quality. Prioritize resilience in tougher markets by reviewing 70 resilient stocks with low risk scores and focusing on companies with more measured risk profiles. Hunt for future...
Investor releaseQuarter not tagged2026-05-05Addus HomeCare: Q1 Earnings Snapshot
Associated Press
Addus HomeCare: Q1 Earnings Snapshot
FRISCO, Texas (AP) — FRISCO, Texas (AP) — Addus HomeCare Corp. (ADUS) on Monday reported first-quarter earnings of $25.1 million. On a per-share basis, the Frisco, Texas-based company said it had profit of $1.36. Earnings, adjusted for one-time gains and costs, were $1.62 per share. The results exceeded Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of $1.52 per share. The provider of home-based personal care, nursing and rehabilitative therapy services posted revenue of $363.6 million in the period, missing Street forecasts. Four analysts surveyed by Zacks expected $364.9 million. Addus HomeCare shares have decreased almost 7% since the beginning of the year. In the final minutes of trading on Monday, shares hit $100.12, a drop of nearly 5% in the last 12 months. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ADUS at https://www.zacks.com/ap/ADUS
Investor releaseQuarter not tagged2026-05-05Addus HomeCare (ADUS) Q1 Earnings Top Estimates
Zacks
Addus HomeCare (ADUS) Q1 Earnings Top Estimates
Addus HomeCare (ADUS) came out with quarterly earnings of $1.62 per share, beating the Zacks Consensus Estimate of $1.52 per share. This compares to earnings of $1.42 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +6.86%. A quarter ago, it was expected that this provider of home-based personal care, nursing and rehabilitative therapy services would post earnings of $1.71 per share when it actually produced earnings of $1.77, delivering a surprise of +3.51%. Over the last four quarters, the company has surpassed consensus EPS estimates four times. Addus HomeCare, which belongs to the Zacks Medical - Outpatient and Home Healthcare industry, posted revenues of $363.61 million for the quarter ended March 2026, missing the Zacks Consensus Estimate by 0.35%. This compares to year-ago revenues of $337.71 million. The company has topped consensus revenue estimates three times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Addus HomeCare shares have lost about 7.3% since the beginning of the year versus the S&P 500's gain of 5.6%. While Addus HomeCare has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Addus HomeCare was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in lin...
Investor releaseQuarter not tagged2026-05-05Addus HomeCare Q1 Adjusted Earnings, Revenue Increase
MT Newswires
Addus HomeCare Q1 Adjusted Earnings, Revenue Increase
Addus HomeCare (ADUS) reported Q1 adjusted earnings late Monday of $1.62 per diluted share, up from
Investor releaseQuarter not tagged2026-05-05Addus HomeCare (ADUS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Zacks
Addus HomeCare (ADUS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended March 2026, Addus HomeCare (ADUS) reported revenue of $363.61 million, up 7.7% over the same period last year. EPS came in at $1.62, compared to $1.42 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $364.9 million, representing a surprise of -0.35%. The company delivered an EPS surprise of +6.86%, with the consensus EPS estimate being $1.52. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance. As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately. Here is how Addus HomeCare performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Revenue- Personal care: $281.09 million versus the two-analyst average estimate of $282.02 million. The reported number represents a year-over-year change of +8.8%. Revenue- Home Health: $16.73 million versus $17.07 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -7% change. Revenue- Hospice: $65.79 million versus $68.8 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +7.1% change. View all Key Company Metrics for Addus HomeCare here>>> Shares of Addus HomeCare have returned +8.7% over the past month versus the Zacks S&P 500 composite's +10% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Addus HomeCare Corporation (ADUS) : Free Stock Analysis Report This article originally published on Zacks Investment Research (zacks.com). Zacks Investment Research
Investor releaseQuarter not tagged2026-05-05Addus HomeCare Q1 Earnings Call Highlights
MarketBeat
Addus HomeCare Q1 Earnings Call Highlights
Strong Q1 financials and balance sheet improvement: Revenue rose 7.7% to $363.6 million, adjusted EPS was $1.62 (vs. $1.42 a year ago) and adjusted EBITDA increased 9.7% to $44.5 million, while cash from operations jumped to $52.4 million and the company held about $103 million of cash with bank debt reduced to roughly $94 million, giving flexibility for larger acquisitions. Personal care drove growth while home health lags: Personal care (77.3% of revenue) grew 8.8% with 6.5% same-store growth and was supported by state rate increases, hospice also posted same-store gains and higher average daily census, but home health revenue declined year‑over‑year even as operating income and volume showed sequential improvement. M&A and operations focus: Addus entered Indiana with two personal-care deals (including HomeCourt’s ~240 clients and ~$9.7 million revenue) and sees larger M&A opportunities in its pipeline, while operational improvements include positive hiring trends and rollout of the Addus Connect caregiver app to improve hours served and engagement. Interested in Addus HomeCare Corporation? Here are five stocks we like better. 3 Healthcare Stocks Providing Relief for the Sandwich Generation Addus HomeCare (NASDAQ:ADUS) reported first-quarter 2026 revenue of $363.6 million, up 7.7% from $337.7 million in the prior-year quarter, as growth in personal care and hospice offset continued pressure in home health. Chairman and CEO Dirk Allison said the quarter produced adjusted earnings per share of $1.62, up from $1.42 a year earlier, while adjusted EBITDA increased 9.7% to $44.5 million. Allison noted that cash flow from operations rose to $52.4 million from $18.9 million in the year-ago quarter. As of March 31, 2026, the company had about $103 million of cash and reduced bank debt to $94.3 million, which Allison said left Addus with “the financial flexibility to consider larger acquisitions.” → Roblox Stock Slides to New Low as Safety Changes Weigh on Outlook Management said revenue in late January was affected by a widespread weather event, which led to missed personal care visits that could not all be rescheduled. Allison estimated the storm-related impact at approximately $1.5 million of lost revenue, adding that February and March returned to normalized expectations. Chief Financial Officer Brian Poff said personal care services accounted for 77.3% of first...
Investor releaseQuarter not tagged2026-05-05Addus HomeCare Corporation Q1 2026 Earnings Call Summary
Moby
Addus HomeCare Corporation Q1 2026 Earnings Call Summary
Performance was driven by strong Personal Care same-store revenue growth of 6.5%, supported by rate increases in Illinois and Texas and consistent hiring trends. The company successfully entered the Indiana market through the acquisition of HomeCourt Home Care, targeting a state with favorable rate support and eliminated client waitlists. Management attributed a slight sequential census decline to a widespread January weather event that resulted in approximately $1.5 million in lost revenue. The hospice segment showed robust growth with an 8.2% increase in average daily census, benefiting from a 'bridge program' that captures internal referrals from home health operations. Strategic positioning remains focused on geographic density and scale, with management noting a shift toward evaluating larger acquisition targets similar in size to the Gentiva transaction. Management expressed optimism regarding the potential elimination of the CMS 80-20 Medicaid access rule provision, which they believe would be a positive development for the industry. Full-year 2026 adjusted EBITDA margins are expected to remain above 12%, supported by ongoing G&A leverage and stable gross margins. Management reported that Personal Care same-store revenue grew 6.5% in the first quarter of 2026 and expects to continue benefiting from rate support in key markets for the remainder of the year. The company expects to close a second acquisition in Indiana in the coming months, further establishing scale in the new market. Management noted that first quarter results were highlighted by a 7.7% increase in top line revenue and a 9.7% increase in adjusted EBITDA, with hospice care showing a year-over-year improvement in average daily census. The tax rate for the full year 2026 is projected to be in the mid-20% range following a lower first-quarter rate due to stock compensation benefits. A $1.5 million revenue headwind was realized in Q1 due to severe weather, though February and March returned to normalized levels. Stock-based compensation expense was elevated this quarter due to accelerated vesting related to the retirement of the former President and COO. Management highlighted the risk of self-directed care models, emphasizing their preference for agency-directed models which offer superior compliance and oversight. DSOs were 63 days at the end of the first quarter of 2026, compared with 38...
TranscriptFY2026 Q12026-05-05FY2026 Q1 earnings call transcript
Earnings source - 151 paragraphs
FY2026 Q1 earnings call transcript
Good morning, and welcome to the Addus HomeCare's first quarter 2026 earnings call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's remarks, there will be an opportunity to ask questions. To ask a question, you may press star then one on your touch-tone phone. To withdraw your question, please press star then two. Please note this event is being recorded. I'd now like to turn the conference over to Dru Anderson. Please go ahead.
Thank you. Good morning, and welcome to the Addus HomeCare Corporation first quarter 2026 earnings conference call. Today's call is being recorded. To the extent any non-GAAP financial measure is discussed in today's call, you will find a reconciliation of that measure to the most directly comparable financial measure calculated according to GAAP by going to the company's website and reviewing yesterday's news release.
This conference call may also contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements, among others, regarding Addus' expected quarterly and annual financial performance for 2026 or beyond. For this purpose, any statements made during this call that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, discussions of forecasts, estimates, targets, plans, beliefs, expectations, and the like are intended to identify forward-looking statements.
You are hereby cautioned that these statements may be affected by important factors, among others, set forth in Addus' filings with the Securities and Exchange Commission and in its first quarter 2026 news release. Consequently, actual operations and results may differ materially from the results discussed in the forward-looking statements.
The company undertakes no obligation to update any forward-looking statements, whether as a result of new information, future events, or otherwise. I would now like to turn the call over to the company's Chairman and Chief Executive Officer, Mr. Dirk Allison. Please go ahead, sir.
Thank you, Dru. Good morning, welcome to our 2026 first quarter earnings call. With me today are Brian Poff, our Chief Financial Officer, Heather Dixon, our President and Chief Operating Officer. As we do on each of our quarterly earnings calls, I will begin with a few overall comments, Brian will discuss the first quarter results in more detail. Following our comments, the three of us would be happy to respond to any questions. As we announced yesterday afternoon, our total revenue for the first quarter of 2026 was $363.6 million, an increase of 7.7% as compared to $337.7 million for the first quarter of 2025.
This revenue growth resulted in an adjusted earnings per share of $1.62 as compared to adjusted earnings per share for the first quarter of 2025 of $1.42, an increase of 14.1%. Our adjusted EBITDA was $44.5 million compared to $40.6 million for the first quarter of 2025, an increase of 9.7%. For the first quarter of 2026, cash flow from operation was $52.4 million as compared to $18.9 million for the same period in 2025. As of March 31, 2026, we had cash on hand of approximately $103 million.
With our strong cash flow in the first quarter, we reduced our bank debt to $94.3 million, leaving us with the financial flexibility to consider larger acquisitions as we continue to pursue expansion of our market reach and creating geographic density. During the first quarter, we saw an impact on revenue due to the widespread weather event that occurred towards the end of January. Our team did a good job of rescheduling affected personal care visits where possible. We could not make up for every weather-impacted missed visit.
While the amount of the revenue was immaterial to our company overall, we did see a loss of revenue of approximately $1.5 million as a result of these storms. February and March returned to our normalized revenue expectations. As we announced on May 1, we closed on the acquisition of the personal care operations of HomeCourt Home Care based in Fort Wayne, Indiana. This acquisition marks our entry into an attractive state which is adjacent to our largest personal care market of Illinois.
We have been interested in Indiana for some time, as over the past three years, they increased rates and worked to eliminate client wait lists. I'm excited to welcome all of our new team members from HomeCourt Home Care. We have also entered into a definitive purchase agreement for an additional personal care operation in Indiana, which will complement HomeCourt Home Care. We anticipate that this additional Indiana acquisition should close in the coming months, subject to customary regulatory approvals.
These two acquisitions continue our strategy of entering new markets with scale and where we have the ability to expand our services. As we mentioned on our last earnings call, the State of Illinois increased our rates in personal care service effective on January 1, 2026, adding approximately $17.5 million in annualized revenues. This most recent rate increase continues to show the important support we are receiving from our state partners as we continue to provide these much-needed services to our elderly and disabled clients.
We also understand the New Mexico Legislature included increased funding of $10 million for home and community-based services in the budget for the upcoming fiscal year. We are waiting for communications from the New Mexico Medical Department regarding how and to which programs the funding will be expended. As we have stated before, we continue to believe that the 80/20 provision of the CMS Medicaid Access Rule will be eliminated in the near future.
While implementation is still several years away and has no current impact on our business or financial performance, we believe this outcome would be an encouraging development for both our industry and our company. All our recent communications indicate that this part of the Medicaid Access Rule is expected to be eliminated this year. During the first quarter of 2026, we continued to experience positive hiring trends in our personal care segment.
Our number of hires per business day in the first quarter of 2026 was 108, up sequentially from 103 hires per day in the fourth quarter of last year and consistent with the first quarter of 2025. We achieved this number in spite of the impact of the weather event I mentioned earlier. As we have mentioned in the last few quarters, our clinical hiring remains consistent and has been mostly stable outside of a few of our urban markets. However, even in those markets, we have been able to staff our operations appropriately. Now let me discuss our same-store revenue growth for the first quarter of 2026.
For our personal care segment, our same-store revenue growth was 6.5% compared to the first quarter of 2025. During the first quarter of 2026, we saw personal care same-store hours increase by 2.2% compared to the same period in 2025, while our percentage of authorized hours served in the first quarter remained consistent with what we experienced in the fourth quarter of 2025. On a sequential basis, personal care same-store census was down slightly, partially due to the weather we mentioned before.
However, during the first quarter, we saw growth in clients served in Illinois, our largest market, which is something we had anticipated for a while. This is important as we look to achieve year-over-year census growth during 2026. Turning to our clinical operations, our hospice same-store revenue increased 7.7% compared to the first quarter of 2025. Our average daily census increased to 3,804 for the first quarter, up from 3,515 for the same period last year, an increase of 8.2%.
For the first quarter of 2026, our hospice medium length of stay was 23 days as compared to 25 days for the fourth quarter of 2025 and 19 days for the first quarter of 2025. We are very pleased by the continued growth in our hospice segment over the past several quarters. While our home health same-store revenue decreased when compared to the same quarter of 2025, our home health operating income improved over last year's first quarter and sequentially versus the fourth quarter of 2025.
It is also important to understand that over 25% of our hospice admissions in New Mexico and now Tennessee are coming from our own Addus Home Health operations, which overlap in these two markets as we continue to focus on our Bridge Program. We are pleased to see more patients receiving the benefit of the full continuum of post-acute home-based care and anticipate seeing similar clinical teamwork develop in Illinois, where we also have both home health and hospice operations.
We continue to believe that size and scale are important to healthcare services and have been the focus of our strategy for the past 10 years. We continue to evaluate opportunities which would increase both density and geographic coverage, as well as seek to further strengthen our relationships with states and managed care organizations. Recently, we have begun to see an increasing number of personal care opportunities. Due to our focus on maintaining a conservative balance sheet, we have the ability to actively pursue these transactions.
Recently, there appears to be more optimism around home health care due to the final Home Health Rule for 2026 being more favorable than was originally proposed. While there is still some uncertainty about the future rate increases, there does seem to be more potential activity in home health care. While we will be open to home health opportunities, we will continue to be diligent as we evaluate possible transactions to further our strategy. Before I turn the call over to Brian, it is important that I thank the Addus team for the care they are providing to our elderly and disabled consumers and patients.
We all have come to understand that the majority of this population prefers to receive care at home, which not only remains one of the safest, but also the most cost-effective places to receive this care. We believe the heightened awareness of the value of home-based care is favorable for our industry and will continue to be a growth opportunity for our company.
We understand and appreciate that our operations and growth are dependent on both our dedicated caregivers and other employees who work so incredibly hard providing outstanding care and support to our clients, patients, and their families. With that, let me turn the call over to Brian.
Thank you, Dirk, and good morning, everyone. The first quarter of 2026 marked a solid start to a new year for Addus. The results for the quarter reflect our continued ability to execute our strategy and deliver consistent growth. Results were highlighted by a 7.7% increase in top line revenue to $363.6 million and a 9.7% increase in adjusted EBITDA to $44.5 million when compared with the first quarter of 2025. Our personal care services segment, which accounted for 77.3% of our revenues, was a key driver of our business.
Revenues for the segment grew to $281.1 million, an increase of 8.8% overall and an increase of 6.5% on a same-store basis compared to the same quarter last year. We are continuing to see contributions from our acquisition of Gentiva's personal care operations in late 2024 and the acquisitions of Helping Hands Home Care Services and Del Cielo Home Care, both of which were acquired in the back half of 2025. The revenues of Gentiva's personal care operations are included in our same-store numbers for the first time this quarter.
In addition to higher volumes, we are continuing to benefit from rate support in some of our key state markets, including our two largest in Illinois and Texas. Our first quarter results included the impact of the 3.9% rate increase in Illinois, which became effective on January 1, 2026, as well as the 9.9% rate increase in Texas that became effective on September 1, 2025. Our hospice care business continued to perform well and accounted for 18.1% of revenues for the first quarter.
Our hospice revenues were $65.8 million, with a same-store increase of 7.7% over the same period last year and year-over-year improvement in average daily census. For the period, home health services, our smallest segment, accounted for 4.6% of first quarter revenue at $16.7 million. We continue to look for ways to support and expand our home health service line, including through acquisitions, as we believe important synergies can be realized by offering multiple levels of home-based care in the markets we serve.
Yesterday, we announced two transactions in Indiana, HomeCourt Home Care based in Fort Wayne, which closed on May first, and the signing of a definitive agreement to acquire additional operations of a similar size in the state. Currently, HomeCourt serves approximately 240 clients with annual revenues of approximately $9.7 million. We anticipate our second acquisition in the state will close later this year. We believe our announced expansion into Indiana, a new market for Addus, is aligned with our strategy of broadening our geographic coverage with density and scale.
Our team looks forward to welcoming the clients and caregivers to the Addus family. We intend to provide additional details on the second acquisition when regulatory considerations permit. Strategic opportunities will continue to play a role in our long-term growth planning. Our primary focus will be on identifying opportunities where we can leverage geographic coverage and density, providing us with a competitive advantage. We will also seek opportunities to add services to meet our ultimate objective of offering multiple levels of care in the markets we serve.
With our size and expanding scale and the support of a strong balance sheet, we are well-positioned to execute our strategy. As Dirk noted, total net service revenues for the first quarter were $363.6 million. The revenue breakdown is as follows. Personal care revenues were $281.1 million, or 77.3% of revenue. Hospice care revenues were $65.8 million, or 18.1% of revenue. Home health revenues were $16.7 million, or 4.6% of revenue. Other financial results for the first quarter of 2026 include the following. Our gross margin percentage was 31.9%, consistent with the first quarter of 2025.
As usual, our gross margin was affected in the first quarter by our annual merit increases and the annual reset of payroll taxes. Looking forward, we anticipate our gross margin percentage will remain relatively stable and consistent with our historical annual pattern. G&A expense was 21.4% of revenue, compared with 21.7% of revenue for the first quarter a year ago. Adjusted G&A expense for the first quarter was 19.6%, compared with 19.9% a year ago, as we continue to generate leverage from our growing revenue base.
The company's adjusted EBITDA for the first quarter of 2026 was $44.5 million, compared with $40.6 million a year ago, an increase of 9.7%. Adjusted EBITDA margin was 12.2%, compared with 12% for the first quarter of 2025. Consistent with 2025, we anticipate our adjusted EBITDA margin percentage for the full year will remain above 12%. Adjusted net income per diluted share was $1.62, compared with $1.42 for the first quarter of 2025.
The adjusted per share results for the first quarter of 2026 exclude the following: Acquisition expenses of $0.06 and non-cash stock-based compensation expense of $0.20, including the impact of accelerated vesting for the previously announced retirement of our former president and COO. The adjusted per share results for the first quarter of 2025 exclude the following: acquisition expenses of $0.13 and non-cash stock-based compensation expense of $0.13. Our effective tax rate for the first quarter of 2026 was 22.7%, benefiting from the excess tax benefit related to our stock compensation.
For the full year 2026, we expect our tax rate to be in the mid 20% range. DSOs were 36.3 days at the end of the first quarter of 2026, compared with 38.2 days at the end of the fourth quarter of 2025, with DSOs for the Illinois Department on Aging at 47.4 days, compared with 54.7 days at the end of the fourth quarter of 2025. As expected, we saw resolution in some of the normal timing differences in payment cycles we experienced around year-end. Our net cash flow from operations was $52.4 million for the first quarter of 2026, a strong start to the year.
As of March 31st, 2026, the company had cash of $103.1 million, with capacity and availability under our revolving credit facility of $650 million and $547.8 million, respectively. Total bank debt was $94.3 million at the end of the quarter, a reduction of $30 million from the end of the fourth quarter of 2025. We have continued to reduce our revolver balance in the second quarter of 2026, with $10 million paid to date. We have a capital structure that supports continued pursuit of our strategic initiatives.
Looking ahead, we expect to maintain our disciplined capital allocation strategy and continue to diligently manage our net leverage ratio while also focusing on enhancing shareholder value. This concludes our prepared comments this morning, and thank you for being with us. I'll now ask the operator to please open the line for your questions.
Thank you. We'll now begin the question-and-answer session. To ask a question, you may press star then one on your touch-tone phone. If you're using a speakerphone, please pick up your handset before pressing the keys. To withdraw your question, please press star then two. In the interest of time, please limit yourself to one question and one follow-up. At this time, we'll pause momentarily to assemble our roster. Our first question comes from Brian Tanquilut from Jefferies. Please go ahead.
Hey, good morning, guys. Maybe I'll start, Dirk, when we think about the caregivers app rollout, I know that's something that you're working on in Texas. How do you think about the progress there and what it will take to get it to where you want it to be as quickly as possible? Then what are the expected benefits from that? I mean, how do we think about the P&L translation of this app rollout and why it's so important?
Hi, Brian. Good morning. I'll start, then Dirk can add to anything that I say. I'll start with just, you know, the progress that we're seeing. With that caregivers app, we now have deployed it in all three of our three largest states. Illinois, as you know, has been deployed for a while, and we're continuing to see really good utilization and uptick of that utilization throughout the state. In New Mexico, we have deployed it for a portion of our branches. We have some special nuances associated with the state's EVV system there, we're gonna roll it out in two tranches.
We have deployed it, and we expect to be deploying to the rest of the branches soon in the coming quarters. Finally, in Texas, we rolled it out during Q1, and we're seeing some really positive momentum in the utilization of that and caregivers actually downloading that app. We saw, even in the first, you know, few days to a week, we saw up over 10% of our caregivers had already adopted that app. We're seeing really good momentum. As we think about where we go from here, you know, there are a couple of things.
One, you know, continue to roll it out to other locations, and that's really gonna enable our caregivers and help us focus on increasing our service percentage. Two, we can use that to really drive communication and really create a good engagement, positive engagement with our caregivers.
Yeah, Brian, I think what Heather just mentioned, they're the two aspects that we really focus on and why we invested in the caregivers app. You know, you've seen positive momentum in Illinois for the % of hours served, that we believe a large part of that is directly attributed to the fact that there's that caregivers app out there which allows the particular caregiver to see how many hours are left on the authorization and make sure that we're serving to an appropriate amount.
Also, we think it can allow us to be a little more sticky, as Heather said, with our caregivers, make it easier for them to know what their paycheck's going to be, to know their hours served, and know also the ability for them if they wanna pick up additional hours, we have this app out there that allows them to be able to do that in an effective manner. Those are really the benefits that we're looking for from this app.
That makes sense. Maybe my follow-up, Heather, for you or maybe for Brian, as I think about the length of stay on the hospice side, you've just gotten questions on cap risk and how you're thinking about that. Just anything you can share with us, just on the hospice cap concern. Thank you.
Yeah, Brian. Right now, we don't really have any cap consideration. We actually are managing, I think, our referral mix and our patient base pretty well. Discharge length of stay was a little higher this quarter, again, those are just a factor of the people that actually discharged during the quarter and probably not indicative of how you would think about cap. Our median length of stay, as Dirk mentioned, was 23 days, which actually is probably a little bit low for us. I think we've got a really good mix, no cap concerns for us at the moment.
Thank you.
Our next question comes from Raj Kumar from Stephens. Please go ahead.
Hi, good morning. Maybe just a update on the kind of the budget from each of your states. I'm curious on kind of Indiana more specifically. I know when you guys went into Texas with Gentiva, that was kind of on the front of, you know, the state passing or kind of in the process of passing a rate update. Curious on the kind of Indiana rate backdrop and any commentary there.
Yeah. I think in Indiana, specifically, I may talk about some other states as well, Raj. You know, Indiana, as Dirk mentioned, we've seen some nice rate support from them over the past several years. I think if you went back, you know, about five years ago or so, I'm not sure it would have been probably quite as attractive for us, but we've seen nice support for them, a nice margin in that state, pretty consistent with where we are on a consolidated basis. I think the ability for us to do two acquisitions simultaneously or in close proximity gives us really good coverage.
I think we've always wanted to have a pretty good footprint when we go into a new market. I think if we were to do, you know, one without the other, it probably wouldn't have been quite as attractive. I think doing both gives us a nice, a nice place to start in Indiana and the ability to continue to add either additional services or more density there. One more place on the map where we have opportunities. I think just thinking about it from a budgetary standpoint, obviously Texas is every other year, so, you know, they're not gonna meet this year, so nothing to really report on that end.
Dirk kind of referenced New Mexico, which has finalized their budget. There are dollars allocated for home and community-based services. We're just trying to determine and get the information on the logistics of how that will pass down to providers.
I mean, I'm sorry, Illinois is our largest market, is still in session, has not been finalized their budget this year. Our understanding is there's conversations, you know, from the union, as we would expect every year, about our services and rates, but nothing to report. We would expect them to probably finalize their budget over the next few weeks. So we'll know, we'll know more then. But those are probably the three largest, obviously, that we keep our eye on.
Got it. Maybe looking at home health, I guess, you know, there was a shift in the payer mix trend, I think higher Medicaid year-over-year. I guess maybe anything to call out on that front, I guess more intentional or just kinda how it played out. I guess, you know, has it been paying better than MA if it is intentional? I'm just kinda curious on the payer mix trend for home health in the quarter.
Yeah, I think in the quarter, probably a little bit of an anomaly. We had some rate updates, some positive rate updates in one of our programs that kind of falls into that other bucket that you saw on our press release yesterday. We saw that in the quarter, but probably revert back to more historical norms next quarter. Nothing intentional.
I think obviously we're focused on making sure we try to get the best rate possible in the business that we take in home health, trying to make sure that it's profitable. Our guys on the payer side are having conversations consistently with folks on trying to get as many episodic rates as we can, and looking at taking cases that make sense for us from a profitability perspective.
Great. Thank you.
The next question comes from Matthew Gillmor from KeyBanc. Please go ahead.
Hey, good morning. Thanks for the question. Maybe following up on some of the census comments for personal care. I think I, you know, saw the census was down a little sequentially. You mentioned Illinois was up, which is encouraging. I just wanted to confirm I heard that correctly. Maybe more broadly, I know census for personal care oftentimes is lower in the first quarter. If Illinois was stronger, does that imply there was weakness elsewhere? Or would you just sort of categorize it as sort of normal seasonal trends? Just wanted to see if there was any other details to share on this topic.
Sure. Sure. I'll take that. Hi, Matt. Good morning. As Dirk mentioned, we did have some weather impact in the beginning of the quarter, and that impacted our sequential census growth. That's what you saw as a slight sequential decline. You did hear correctly. We had census improvements throughout the quarter, and we saw gains as we exited the quarter. I think very importantly, March census exceeded both January and February census. We're focused on those sequential gains, and going forward, that should lead to year-over-year gains as we move through the next couple of quarters.
Then specifically in Illinois, we were very pleased to see that start the care exceeded discharges throughout the quarter, and that led to sequential monthly improvement there as well. As we exited the quarter for Illinois, we saw a nice trajectory and frankly overall with census, and then we saw that trajectory really continue as we moved into the second quarter as well. There is nothing to point to. It's not that Illinois is masking anything else. It's just as our largest state and one that we're very focused on, we wanted to be sure that we shared, you know, the positive improvement that we've seen there.
That's great. Appreciate it. Then maybe following up on some regulatory topics. You know, CMS has made some comments that have been skeptical of the self-directed care model within personal care and sort of home and community-based services broadly, you know, especially with some key states like New York, which I know you don't have exposure to. I was curious if the skepticism on the self-directed care model created opportunities for Addus more broadly, given, you know, your focus on the agency-directed model.
Yeah, you know, self-directed care does have an issue. You don't have anybody in between the patient and the caregiver, the caregiver and the patient to make sure that the service is actually being performed. The state has a little more responsibility on themselves to do that. We saw in New York that it was a program that was probably, in our mind, gonna have issues and not really sustainable. It's why we left New York. There's also issues out in California. There's a large issue out there because it's self-directed care.
We don't participate in Medi-Cal out there, most of the business we have is VA and private pay. As you look at it, we've been saying for years, personal care is a great service and much needed and saves the states a lot of money, it needs to be done in the right way. One of the things that is an advantage to having the companies like Addus and others sit out there hiring the caregiver and matching them with the patient, is that we have responsibilities to do a lot of extra things to make sure that service is being provided. Whether that's supervisory visits, actually in-person calls on the telephone, we have EVV.
We have to make sure that the client shows up. I mean, the caregiver shows up and stays the amount of time when they leave so that we're billing a proper number of hours. There's a lot of compliance issues that are placed on companies like Addus, as opposed to the self-directed care where there's very little, if any of those. We think it's a real encouragement to our industry. From our standpoint, we agree with the fact that there needs to be a look and make sure that when you're paid for services, those services are being rendered. We think that will benefit a company like Addus.
Great. Thank you.
The next question comes from Sean Dodge from BMO Capital Markets. Please go ahead.
Great. Thanks for taking our questions. It's Christopher Charlton on for Sean here. Maybe back on personal care. You've again driven strong growth and same story, billable hours, even amid a declining census. Can you just share some more detail on some of the dynamics behind the strength here and continuing to fill a strong percentage of the authorized hours and kinda how you anticipate that evolving throughout the year as you expect to return to some census growth?
Sure. Sure, I'll take that. Hi, Chris. I'll start with talking about billable hours and sort of what we're doing that really fuels that growth in billable hours. Couple of things. Specifically, one, you know, we're working on refining our operational processes, you know, from the support center and then also from the branch perspective, and that's particularly with scheduling and utilization of our authorized hours.
As we talked about just a couple of minutes ago, we've been focused on creating tools and deploying them that will help our providers, actually the caregivers, have access to those hours as well, and that's in the form of the app. What we have seen is improvement in that service percentage or fill rate. The hours that we are posting are really a higher utilization of the authorized hours. We're seeing that, you know, in most of our states, and we're seeing that specifically where we have deployed the app, and we've had some really good usage.
We would expect for that opportunity to improve the service percentage to improve as we move throughout the year, particularly as we deploy the app in Texas, one of our largest states. If you think about from Q4 to Q1, you know, your question about even though census is down just a bit sequentially, billable hours are up, I think that's just a function of the weather that we saw earlier in the quarter and nothing else really to point to there.
I think let me jump in on census because I know, you know, everybody's focused on that number, and it is an important number. It's not one that, you know, we get paid on billable hours, so we really focus on making sure we get the proper amount of hours per census as opposed to just census per se. You gotta get the right census. You gotta get the right hours from that patient coming on board to make sure that it's something we can serve appropriately and profitably.
That being said, we do understand that people are looking at that, and I think the important thing this quarter that's very exciting to us is Illinois made the turn. Illinois is one we've really worked on the last four quarters to get it back into a growth mode. It just so happens this month, Texas was a little soft coming out in January, really. We saw a little bit of effect in Texas for the census for the quarter. By the end of the quarter, Texas was back, Illinois was continued to grow.
The important thing is we believe most of our states now are in the situation where starts of care are exceeding discharges. Sometimes you're gonna have a little bit of issue in a state maybe during a quarter. The general trend is we think we've seen that change, and now we think all three of our big states are in that particular situation where we should grow census.
Okay, that's helpful. Then on home health, obviously, there was some encouraging adjustments to the final rate from CMS there last year. As you kinda come up on their initial proposal for 2027 rates in the coming months, maybe just qualitatively, can you just share some thoughts on the backdrop and kind of what you would like to see initially just to kinda give everyone some clarity that the environment might be starting to stabilize and might be looking just to be a more favorable backdrop for some opportunities there?
Yeah, I think I can take that one, and Dirk can add some color as well. I think, you know, in Dirk's comments, you know, I think obviously saw some positivity in the final rule last year. I think we're interested to see what the rule will look like this year. It feels like maybe there's more, you know, appreciation coming out of CMS for, you know, what the industry has gone through the last few years. I think in kind of focusing on some of the areas where there might have been, you know, some issues that might have impacted, you know, the way that they've looked at reimbursement the last few years.
The industry, I think, has been lobbying for some time for them to see that, and the way that some of the things in the fraud, waste, and abuse area potentially have been used in the calculation. With those kind of maybe out of the mix and maybe identified, I think we're hopeful that it means maybe there'll be more positivity in the rate that we'll see coming up this year. You know, a small segment for us. We think there's a lot of synergies of having multiple lines of care. Something that we'll watch closely, but things that we're still interested in looking at.
Great. Thanks again.
The next question comes from Andrew Mok from Barclays. Please go ahead.
Hi, good morning. This is Jefferson Rives on for Andrew Mok. I appreciate all the color around the personal care segment, but maybe I just wanted to better understand Addus HomeCare's exposure to self-directed personal care and the impact that's had on recent personal care segment results.
Yeah. You know, we don't really see an impact from self-directed care in most of our states. As we mentioned, there was some issues in New York. We left that state. California, if you go back 10, 15 years ago, we did business in California, and California really decided to go self-directed care, and it wasn't something that we provided. We focused on states that really understand the difference between self-directed care and agency care. That really goes back to what I said a few minutes ago, which was, what you get with agency care is a compliance program.
You get companies like Addus that are making sure that that caregiver, who may or may not, just because it's called, you know, family caregiver, it may not actually be a family caregiver or family member. It may be somebody that knew the patient and is willing to serve in that market. For that aspect, we still do all the things. We do all the training. We make sure that EVV is in place.
We go through our complete compliance program to make sure that we are being paid appropriately and that we're providing the appropriate care that per the plan of care. Really from us, the self-directed care does not have a direct impact, but we are glad to see that they're looking at self-directed care to make sure that it is following the rules just like agency care.
Okay, thanks. Maybe on the hospice side, I think revenue per patient day growth was negative for the first time in a while. Could you help us better understand the dynamics there, including any trade-off with average length of stay? Thanks.
I think there's two elements to that this quarter. I think primarily, you know, we talked last year that we had some positive impact from the implicit price concession or revenue adjustment, whichever term you wanna use. I think we had indicated we expected that to revert back to kind of historical norms, and I think that's where we were this quarter. I think there's a little bit of probably impact from just mix as well, but nothing really material there. Those are really the two factors.
Okay, thanks.
The next question comes from Constantine Davides from Citizens. Please go ahead.
Thanks. Dirk, you highlighted your balance sheet strengths and ongoing debt reduction both in the quarter and post the quarter. I guess, can you just comment a little bit on the size of the opportunities in the M&A pipeline, whether that's starting to skew up a little bit more in recent months?
Yes. You know, what we're starting to see this year, there's already two or three opportunities out there that are of size that we're looking at. I think it's really something that changed probably in the last three months or so, where we're seeing processes begin on these larger opportunities. That's one of the reasons I think, Constantine, that we've worked very hard to keep our balance sheet clean.
It's the reason we were able to do Gentiva very quickly and bring it on board. We're looking at some of these bigger opportunities that because of our balance sheet, we could do and bring on fairly rapidly without having to stress our balance sheet. Again, they are out there. They're in a process, and we're looking at them.
When you say of size, something along the size of a or scale of a Gentiva?
Yes. They're similar in size to Gentiva. That's correct.
Great. A quick follow-up on Indiana. You talked about that state being attractive and good rate momentum, I guess, in recent periods. Where do rates kinda compare to either other states you're in or your blended average?
The rates are a little higher than some of the Midwestern states. I mean, obviously, Illinois is gonna be our highest market. Indiana, if you look around the other states around there, the rates now are very, they are nice rates. They're rates that we can operate in very effectively. Also, there seems to be a little less competition in Indiana in the number of providers of our care. It's a state that we've been looking at.
With the, you know, I think it was in 2023 timeframe is when they really raised their rates to make them more competitive. Ever since then, we've been looking for opportunities to get into a state. That's what, you know, HomeCourt HomeCare brought to us and the other acquisition that we announced, allow us to get into that state and start looking for other opportunities to grow.
Thank you.
The next question comes from Ryan Langston from TD Cowen. Please go ahead.
Hi. Maybe just a dovetailing off Indiana, you know, obviously strategy to enter states of size and scale, do you know if you combine the two assets, where that would put you in terms of market share in the state? I just caught your comments on decent rates and competition dynamics, anything else in particular that made Indiana attractive?
I can start, Dirk can add some color. I don't know that we have enough detail to know exactly where we'd stand. I think it's gonna be a good footprint for us from just a coverage standpoint. You know, all in, the other acquisition is gonna be similar size, we're gonna be, you know, just under $20 million in revenue, which is a pretty good start for us in this state. I think one of the things that made it attractive for us, in addition to what Dirk had kinda referenced, is the managed Medicaid component.
Obviously, a lot of the larger players there, think UnitedHealthcare and those folks, we have good relationships with all of those guys, as everyone knows, kinda nationally. I think it is a good fit for us as well. That's always been something that's been part of the profile that we like, is to get into states that have managed Medicaid, where we can have those relationships in place. I'm excited about that.
Okay. Then appreciate the commentary and response to Matt's question, but maybe just more broadly, obviously, this administration is really focused on fraud, waste, and abuse and have made some, you know, statements to that, you know, quite a bit over the past, you know, several months to a year plus. Like, I guess, just in general, what do you think any of that could mean for Addus?
Is that a potential benefit because you're so large and so, you know, sophisticated maybe versus some of your smaller, you know, competitors in your markets? Just maybe more broadly, what do you think this administration sort of stance on FWA, you know, and how that could affect Addus? Thanks.
You know, one of the things that Addus did, we participated with The Alliance in talking to the current administration about the fact that fraud and abuse is out there, and it causes companies that are legitimate providers, it causes issues with various things you can talk about. From the standpoint of Addus, we're glad to see the administration focus on fraud and abuse. We spend a lot of money on compliance. We have for the last 10 years. We wanna make sure that when we operate in a state, that we're following the rules, and we're doing what's proper.
You know, at times that you find that maybe something was billed improperly, we pay it back very quickly to stay in compliance with the state. The fact that we are large, we spend millions of dollars into the compliance aspect, we think bodes very well for what the administration is trying to do, and that is take out the players, mostly smaller players, but take out the players that aren't doing the right thing. They're just billing and not following through with what they need to do to make sure that the rules are being followed. More importantly, the most important thing is that the care is being given to the patient.
There's a reason that patient has a plan of care that the state approved, and that is they need that care. For us, you know, calling out personal care, you know, we'd rather them just call out home care and talk about the fact that there's a lot of fraud and abuse in home health. There seems to be a lot in hospice. From a personal care standpoint, we believe that we're a leader in the industry, and part of that being a leader is to lead the compliance effort. We're pleased with the fact they're focused on that, and we believe long-term, it'll be a benefit to our company.
Great. Thank you.
The next question comes from Jared Haase from William Blair. Please go ahead.
Hey, guys. Good morning. Maybe just one for the model. Appreciate all the detail you guys have given as far as hiring and some of the initiatives you have going on, like the caregiver application. You know, that hours per census per month metric has been above 70 for a couple quarters now. I guess, is there anything structurally that would cause that to decline?
I think the typical seasonality would have that, you sort of continue to grow sequentially over the rest of the year. Just wanna kinda make sure that's sort of the right expectation to level set how we're thinking about things for the model, just given the moving parts as it relates to sort of census and volume trends.
Yeah, Jared, I wouldn't expect to see that. There's nothing structurally that's gonna cause that to decline. I think you're always gonna have a little bit of ebb and flow and mix in the states. With the efforts that we're using in the Addus Connect and that rollout and thinking about our co-rate, we would actually probably expect that longer term to actually continue to grow, 'cause we think there are hours that are available for clients under their care plan that we are currently not serving. No, I wouldn't expect from a modeling perspective, I would not expect to see that decline for any structural reason.
Okay. Got it. That's helpful. Maybe just another one on Indiana as a new market for you guys. You know, I'm just curious, do you get any sort of regional leverage in a market like Indiana, just given obviously the proximity to your largest market, Illinois? I don't know if there's any sort of infrastructure that you're able to leverage that would help you scale up and extract synergies a little bit more quickly than normal.
Yeah. I think if you look at even where we have markets around Indiana, obviously we're very large in Illinois, we're in Michigan, we're Ohio, Indiana is kind of right in the middle of that geographically. If you think about from a, just a regional or leadership perspective, there's not going to be a need for us to add any additional layers there.
They should be able to just tuck under kind of what exists for us on the infrastructure today. Obviously, you'll have people, you know, in those branch locations, but really that should be the limit of it. From a, just from a leverage perspective on G&A, that definitely should slide right into the operations that we have that kind of surround the state.
Okay. Thank you.
The next question comes from Clarke Murphy from Truist. Please go ahead.
Hey, good morning, guys. Thanks for taking my question. I had a follow-up on labor. I appreciate all the commentary that you guys gave around the Addus Connect and hiring trends. Wanted to see if you guys are seeing perhaps any benefit on labor availability, given some of the macro concerns that seem to have amplified over the last couple of months and the impacts that that's had on kind of the broader consumer environment.
Yeah. Hi, good morning, Clarke. I'll take that. You know, the short answer is that we're seeing, you know, positive hiring trends, and we are seeing, you know, some of the leading indicators in terms of wage inflation and availability of candidate all trend in the right direction. Frankly, with wage inflation, we're back to sort of that normal, roughly 3% base, you know, some are a little higher, some are a little lower. In terms of candidates, we're seeing really good candidate flow across our markets.
You know, as Dirk mentioned, we're always gonna have small pockets where it's a little bit more difficult to staff, but that is really limited to mostly rural locations and frankly, just a couple of skilled categories in those rural locations. We continue to work through those so that we can make sure we're hiring the right staff to drive growth and to serve our patients and clients. You know, really seeing some good trajectory there. Now, whether it's attributable to the macro environmental issues, you know, that's really hard to say, of course, but I can tell you that we are seeing positive trends.
Got it. Thanks. Just switching gears to capital deployment. The other question I had was just, you know, if I think about your current pace of debt paydown relative to your debt balance suggests, you know, absent M&A, you'd be kind of largely paid off by the end of the year. Just wanted to see, you know, absent any large scale M&A, how that would potentially impact your capital deployment priorities going forward.
You know, we spent a lot of time talking about this at our board meeting, as you would expect, with the company in our position. I think the thing we see that maybe is not as apparent to outsiders is the number of deals that are now starting to come on board. We're starting to see some larger transactions, as we mentioned. And remember, with those larger transactions, there still are a number of smaller transactions that we just announced that are out there that we consider, in most cases, backfill. In this case, it was entering into a new market.
You know, we believe that before our debt is paid off, we will put to work a great deal of our capital in these opportunities that are out there. It led us to decide that that's really what we understand we're gonna use our capital for today. If that didn't happen over the next year, you would see us maybe come up with a different decision on how we used our capital. We believe right now that with the opportunities that are there for us, we'll be able to use our debt and and our cash and debt to grow the company.
The next question comes from Ben Hendrix from RBC Capital Markets. Please go ahead.
Hi, this is Michael Murray on for Ben. Thanks for taking my question. You saw some pretty good leverage on adjusted SG&A, even with the weather headwinds. Are there specific cost initiatives driving this improvement? Do you think the Caregiver app is helping there? How should we think about SG&A ratio as we move through the year?
I would say first, the Caregiver app, you know, probably isn't gonna really have an impact on G&A. I think what we continue to see is kinda ongoing leverage, particularly on our corporate G&A as we grow our revenue base, as we would expect. We're not having to obviously add incremental costs there. I think, you know, on the labor side, you know, as we kinda mentioned earlier, you know, this year and this cycle, we're back to kind of a, you know, 3-ish percent, kinda default rate there, kinda back to norm.
I think, you know, kinda going forward, we do give our merits on March 1, if you think sequentially into Q2, there's gonna be, you know, a little bit of additional dollars in G&A in Q2 as those kind of flow through for the full quarter, but nothing else really from a seasonal perspective. I think we would expect it to maintain, you know, pretty stable percent of revenue and continue to see additional leverage as we grow.
Okay. Then, just shifting gears to Home Health. Organic revenue declined, 6.6%. I think you previously indicated a return to growth in the second half this year, against some easier comps. Just wanted to get an update on admission trends, the impact of your new leadership, and, your confidence in achieving that timeline.
Sure. Hi, Michael. I'll take that one and talk about Home Health. I just start by reminding everybody it's less than 5% of our business. You know, that said, we've made changes from a leadership perspective and then also from a sales perspective on how we go to market for that business recently. In Q1, we saw our margins really where we want them to be, our focus is now on volume. We did see some positive trends in Q1. In fact, in Q1 2026, new admissions, total volume, and total visits all improved sequentially versus Q4 2025. That is the trend that we would like to see.
That's part of what we're focused on seeing, and we continue to think that we'll see that certainly later this year and feel good about that statement. Just to step back a little bit at a higher level, picking up on something that Dirk said earlier, the real value in our home health business is the interconnecting care that we provide and the correlation that we see in markets where we have multiple lines of service there and different levels of care between those lines of service.
For example, I think it bears repeating, in New Mexico and also Tennessee, where we have what we call the Bridge Program in place, and we really focus on creating referrals and admissions from Home Health into hospice for patients where that's appropriate. We've seen those rates exceed 25%. We've also now begun that program in Illinois. Obviously Addus Home Health is a little bit earlier for us, but there is great opportunity there and opportunity to continue that pattern.
All right. Thank you.
Again, if you have a question, please press star then one. Our next question comes from A.J. Rice from UBS. Please go ahead.
Hi, everybody. First, I think at one point you had said that you thought in the second quarter you'd still see above average growth in personal care and hospice, and then it would moderate in the second half. Just wanted to give you a chance if there's any update, excuse me, to your thinking about seasonality, what that might be, or if there's any comments on it, thinking about the seasonal layout of business for the rest of the year.
A.J., this is Brian. I think maybe not so much seasonal, but I think you start thinking about comps over prior year and some of the rate impact, particularly in personal care. I think our prior comments that we expected to be probably at the high end of our kind of normal three to five range, if not above. Starting this year, obviously at 6.5% on a same-store basis. You know, we would still expect that to be the case for the remainder of this year. I think once we kind of get confirmation on New Mexico and that flowing through as well, that obviously benefit the back half of the year.
I think we still feel pretty comfortable with that commentary, thinking about kind of where we'll be on a same-store basis for each quarter going forward in PCS. You know, I mean, sorry, hospice, you know, has been, you know, double-digit plus in same-store. I think we had, you know, guided people to think that's probably not, you know, long-term sustainable. You know, our ultimate, you know, expectation is probably, you know, upper single digits.
We're, you know, just under 8% this quarter. I think we've seen some nice trajectory in ADC coming out of the quarter. We were a little bit softer coming off of the holiday, so I think that sets us up pretty well, I think going forward to be in really good shape to continue to meet that as well for the remainder of this year.
Okay. Thanks on that. I guess to your comments about M&A and the pipeline and so forth, obviously these deals are more in the personal care arena. You sound like you're feeling a little better about the home health backdrop. Would that be something you would now sort of lean into again on M&A, or is it still too early to do that?
You know, I think we would look at home health deals today as opposed to maybe a year ago. As you can understand, we'd be very careful in what we did, make sure it strategically met. For us, they overlap with our hospice and personal care so that our Bridge Program can work. Yes, we would start looking at home health care opportunities today.
Okay. All right. Thanks a lot.
Thank you.
The next question comes from Joanna Gajuk from Bank of America. Please go ahead.
Hey, good morning. Thanks for squeezing me in. Thank you. A couple of questions here. On personal care, same store hours per business day, I think, grew call it 2%, 2.2%. What was it excluding weather? I know you gave, you know, a revenue, I guess, impact from that. What was it as you exited the quarter? Essentially what I'm trying to get at is kinda, you know, what was your growth in March? Do you expect sort of, you know, re-acceleration and a little bit higher growth the rest of the year on that metric?
I think, Joanna Gajuk, I think, you know, our target has always been, and we've been talking about it for some time now, if we can keep, you know, that same store hours per business day between 2% and 2.5%, you know, we're probably going to be in a pretty good spot. We've been 2.4% each of Q3 and Q4, you know, 2.2%, but we were a little bit softer, as we kind of mentioned and Heather Dixon, with some of the weather we saw in January.
You know, we're probably not going to go into kind of a month-by-month metric on that. I think we feel pretty comfortable, coming out of the quarter with where we were from just a census perspective and hours in March and going into Q2. That, you know, that 2%-2.5% range still feels very, very solid for us going forward.
Okay. That's great. 2.5%. The gross margins, Q1 is seasonally low, right? Can you help us kind of call out anything about Q2 from Q1?
Yeah, I think Q1, yes, seasonally is usually always our low water mark of the year, with the reset of payroll taxes and our merits. I think traditionally what we see is usually you see a little bit of improvement, with some of the payroll tax caps getting hit, Q1 into Q2. Usually there's a little bit of benefit into Q2. Q2, Q3, usually pretty flat. I think Q4 usually is the best quarter for us from a margin perspective, just with some additional benefit from payroll tax caps, but also our hospice rate increase kicks in in that quarter as well.
I think, you know, if you look at the mix of our business, you know, personal care was a little over 77% this quarter. As a just a comparison, you think about that versus hospice and Home health. Hospice and home health have a higher gross margin. If that mix gets back more to 75/25 on skilled and non-skilled, that would benefit as well, but mix is gonna potentially play in as well. I think we feel really good coming out of the quarter on the track for hospice and ADC. If that were to be a bigger part of our mix going forward, that would benefit our gross margin percentage as well.
The last one on the quarter, the stock comp was higher sequentially from Q4. Was there something kind of one-time in nature? Is the $5 million essentially a good run rate, or just something outside of just regular? Thank you.
Yeah, that's not a run rate. I mentioned in my comments. With our former president, COO retiring, there was some accelerated vesting as part of his retirement that impacted the quarter. Should be one time and would not be continuing going forward.
All right. Thank you so much.
Thank you.
This concludes our question and answer session. I would like to turn the conference back over to Dirk Allison for any closing remarks.
Thank you, operator. I want to thank each of you for taking the time to join us today on our call, and we hope that you have a great week. Thank you.
The conference has now concluded. Thank you for attending today's presentation. You may now disconnect.
Investor releaseQuarter not tagged2026-04-20Addus HomeCare Announces First Quarter 2026 Earnings Release and Conference Call
Business Wire
Addus HomeCare Announces First Quarter 2026 Earnings Release and Conference Call
FRISCO, Texas, April 20, 2026--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS), a provider of home care services, announced today that it will release earnings for the first quarter ended March 31, 2026, on Monday, May 4, 2026, after the market close. Addus HomeCare will host a conference call on Tuesday, May 5, 2026, at 9:00 a.m. Eastern Time. Joining the call from the Company will be Dirk Allison, Chairman and CEO, Brian Poff, Executive Vice President and CFO, and Heather Dixon, President and COO. To access the live call, dial (833) 629-0620 (international dial-in number is (412) 317-1805) and ask to join the Addus HomeCare earnings call. A telephonic replay of the conference call will be available through midnight on May 12, 2026, by dialing (855) 669-9658 (international dial-in number is (412) 317-0088) and entering pass code 7882999. A live broadcast of Addus HomeCare’s conference call will be available under the Investor Relations section of the Company’s website: www.addus.com. An online replay will also be available on the Company’s website for one month, beginning approximately two hours following the conclusion of the live broadcast. About Addus HomeCare Addus HomeCare is a provider of home care services that primarily include personal care services that assist with activities of daily living, as well as hospice and home health services. Addus HomeCare’s consumers are primarily persons who, without these services, are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. Addus HomeCare’s payor clients include federal, state, and local governmental agencies, managed care organizations, commercial insurers, and private individuals. Addus HomeCare currently provides home care services to approximately 62,500 patients and consumers through 262 locations across 23 states. For more information, please visit www.addus.com. View source version on businesswire.com: https://www.businesswire.com/news/home/20260420950276/en/ Contacts Brian W. Poff Executive Vice President, Chief Financial Officer Addus HomeCare Corporation (469) 535-8200 [email protected] Dru Anderson FINN Partners (615) 324-7346 [email protected]
Investor releaseQuarter not tagged2026-03-06Q4 Earnings Roundup: Addus HomeCare (NASDAQ:ADUS) And The Rest Of The Senior Health, Home Health & Hospice Segment
StockStory
Q4 Earnings Roundup: Addus HomeCare (NASDAQ:ADUS) And The Rest Of The Senior Health, Home Health & Hospice Segment
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Addus HomeCare (NASDAQ:ADUS) and the best and worst performers in the senior health, home health & hospice industry. The senior health, home care, and hospice care industries provide essential services to aging populations and patients with chronic or terminal conditions. These companies benefit from stable, recurring revenue driven by relationships with patients and families that can extend many months or even years. However, the labor-intensive nature of the business makes it vulnerable to rising labor costs and staffing shortages, while profitability is constrained by reimbursement rates from Medicare, Medicaid, and private insurers. Looking ahead, the industry is positioned for tailwinds from an aging population, increasing chronic disease prevalence, and a growing preference for personalized in-home care. Advancements in remote monitoring and telehealth are expected to enhance efficiency and care delivery. However, headwinds such as labor shortages, wage inflation, and regulatory uncertainty around reimbursement could pose challenges. Investments in digitization and technology-driven care will be critical for long-term success. The 7 senior health, home health & hospice stocks we track reported a slower Q4. As a group, revenues beat analysts’ consensus estimates by 1.1%. Amidst this news, share prices of the companies have had a rough stretch. On average, they are down 6.4% since the latest earnings results. Serving approximately 66,000 clients across 22 states with a focus on "dual eligible" Medicare and Medicaid beneficiaries, Addus HomeCare (NASDAQ:ADUS) provides in-home personal care, hospice, and home health services to elderly, chronically ill, and disabled individuals. Addus HomeCare reported revenues of $373.1 million, up 25.6% year on year. This print was in line with analysts’ expectations, but overall, it was a mixed quarter for the company with a beat of analysts’ EPS estimates. Commenting on the results, Dirk Allison, Chairman and Chief Executive Officer, said, “Our fourth quarter results marked a strong finish to a successful year of growth and progress for Addus. Net service revenues increased 25.6% and adjusted EBITDA was up 33.3% over the fourth quarter of 2024. For the full year, w...
Investor releaseQuarter not tagged2026-02-28A Look At Addus HomeCare (ADUS) Valuation After Its Strong Fourth Quarter Earnings Beat
Simply Wall St.
A Look At Addus HomeCare (ADUS) Valuation After Its Strong Fourth Quarter Earnings Beat
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Addus HomeCare (ADUS) just delivered a fourth quarter that topped analyst expectations on both revenue and adjusted earnings, with over 25% year on year growth helped by acquisitions and expansion in personal care and hospice. See our latest analysis for Addus HomeCare. Despite the strong fourth quarter and talk of further acquisitions, the recent share price has been under pressure, with a 7 day share price return of 9.52% and a 90 day share price return of 13.46%. The 1 year total shareholder return of 7.51% and 5 year total shareholder return of 11.84% show a more constructive longer term picture. If this update on home care services has you thinking about where growth capital might head next, it could be worth scanning 29 healthcare AI stocks as a starting list of healthcare names to research. With the shares down over the past month despite earnings and an intrinsic value estimate that sits well above the current US$104.02 price, the key question now is simple: is Addus temporarily mispriced or already reflecting its future growth? The most followed narrative places Addus HomeCare's fair value at $142.91, well above the last close at $104.02, which sets up a clear valuation gap for investors to assess. Read the complete narrative. Want to see what is baked into that higher fair value? The narrative leans on sustained revenue gains, firming margins and a future earnings multiple that assumes real staying power. Curious which specific growth and profitability assumptions underpin that $142.91 figure and how they connect back to today's price near $104? Result: Fair Value of $142.91 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, there are still real pressure points here, including potential Medicare payment cuts for home health and ongoing wage and staffing challenges that could squeeze margins. Find out about the key risks to this Addus HomeCare narrative. All of this might sound optimistic, but the real test is how you interpret the numbers and risks for yourself. Take a closer look at 5 key rewards. If you stop here, you risk missing other opportunities that could fit your style, so keep going and let the screener surface a few fresh candidates. Zero in on value by scanning 54 high qu...

